We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Automated Collection of CTCs Improves Prostate Cancer Diagnosis

By LabMedica International staff writers
Posted on 16 Sep 2019
Print article
Image: The Parsortix system for collection of circulating tumor cells (Photo courtesy of ANGLE plc).
Image: The Parsortix system for collection of circulating tumor cells (Photo courtesy of ANGLE plc).
A recent paper described the benefits of circulating tumor cell (CTC) analysis for improving the diagnosis of aggressive prostate cancer beyond currently used PSA (prostate specific antigen) measurement, biopsy and/or MRI imagery.

PSA testing can result in unnecessary biopsies and over-diagnosis with consequent over-treatment. Tissue biopsy is an invasive procedure, associated with significant risk of complications. More accurate non- or minimum-invasive diagnostic approaches are required to avoid unnecessary prostate biopsy and over-diagnosis.

Towards this end, investigators at Queen Mary University of London (United Kingdom) evaluated the potential of using circulating tumor cell analysis for prostate cancer diagnosis, particularly in predicting the presence of clinically significant prostate tumors in patients prior to biopsy.

The investigators used the ANGLE plc (Surrey, United Kingdom) Parsortix system to capture and analyze CTCs from 98 pre-biopsy and 155 newly diagnosed prostate cancer patients.

The Parsortix liquid biopsy process requires a blood sample - typically 10 milliliters in an EDTA vacutainer tube. As no pre-processing is required, the tube is simply attached to the Parsortix instrument. A Parsortix filtration cassette is inserted into the instrument and the system is primed for use. The instrument automatically passes the blood through the filtration cassette, and CTCs are caught in the cassette due to their larger size and lower compressibility as compared to other blood components.

Once trapped in the cassette, CTCs may be automatically stained with selected antibodies, which enables their identification and characterization. In addition, CTCs may be enumerated by placing the filtration cassette under a fluorescent microscope. Alternatively, cells may be eluted from the cassette and recovered in buffer solution for genomic analysis.

Results obtained with the Parsortix system indicated that the appearance of CTCs in pre-biopsy blood samples was indicative of the presence of aggressive prostate cancer. When the CTC tests results were combined with those of the current PSA test, the presence of aggressive prostate cancer in subsequent biopsies was predicted with accuracy of over 90%, better than any previously reported biomarkers.

Senior author Dr. Yong-Jie Lu, professor of molecular oncology at Queen Mary University of London said, "The current prostate cancer test often leads to unnecessary invasive biopsies and over-diagnosis and over treatment of many men, causing significant harm to patients and a waste of valuable healthcare resources. There is clearly a need for better selection of patients to undergo the biopsy procedure. Testing for circulating tumor cells is efficient, non-invasive, and potentially accurate, and we have now demonstrated its potential to improve the current standard of care. By combining the new CTC analysis with the current PSA test, we were able to detect prostate cancer with the highest level of accuracy ever seen in any biomarker test, which could spare many patients unnecessary biopsies. This could lead to a paradigm shift in the way we diagnose prostate cancer."

The study was published in the August 7, 2019, online edition of the Journal of Urology.

Related Links:
Queen Mary University of London
ANGLE plc

Platinum Supplier
Xylazine Immunoassay Test
Xylazine ELISA
Gold Supplier
Rapid Flu Test
Influenza A&B Rapid Test Kit
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Universal Laboratory Centrifuge
CF-350

Print article

Channels

Clinical Chemistry

view channel
Image: A module with eight micro-devices, complete with microfluidic channels and drive motors (Photo courtesy of U.S Department of Energy)

Highly Sensitive pH Sensor to Aid Detection of Cancers and Vector-Borne Viruses

Understanding the acidity or alkalinity of substances through pH measurement is crucial in many fields, from environmental monitoring to healthcare product safety. In many cases, these measurements must... Read more

Hematology

view channel
Image: The QScout hematology analyzer has received US FDA 510(k) clearance (Photo courtesy of Ad Astra Diagnostics)

First Rapid-Result Hematology Analyzer Reports Measures of Infection and Severity at POC

Sepsis, a critical medical condition that arises as an extreme response to infection, poses a significant health threat. It occurs when an infection triggers a widespread inflammatory response in the body.... Read more

Immunology

view channel
Image: PointCheck is the world’s first device for non-invasive white cell monitoring (Photo courtesy of Leuko Labs)

World’s First Portable, Non-Invasive WBC Monitoring Device to Eliminate Need for Blood Draw

One of the toughest challenges for cancer patients undergoing chemotherapy is experiencing a low count of white blood cells, also known as neutropenia. These cells play a crucial role in warding off infections.... Read more

Microbiology

view channel
Image: Current testing methods for antibiotic susceptibility rely on growing bacterial colonies in the presence of antibiotics (Photo courtesy of 123RF)

Rapid Antimicrobial Susceptibility Test Returns Results within 30 Minutes

In 2019, antimicrobial resistance (AMR) was responsible for the deaths of approximately 1.3 million individuals. The conventional approach for testing antimicrobial susceptibility involves cultivating... Read more

Pathology

view channel
Image: AI methods used in satellite imaging can help researchers analyze tumor images (Photo courtesy of Karolinska Institutet)

AI Approach Combines Satellite Imaging and Ecology Techniques for Analysis of Tumor Tissue

Advancements in tumor imaging technology have significantly enhanced our ability to observe the minute details of tumors, but this also brings the challenge of interpreting vast amounts of data generated... Read more

Technology

view channel
Image: Made-to-order diagnostic tests may soon be on the horizon (Photo courtesy of McGill University)

Breakthrough in Diagnostic Technology Could Make On-The-Spot Testing Widely Accessible

Home testing gained significant importance during the COVID-19 pandemic, yet the availability of rapid tests is limited, and most of them can only drive one liquid across the strip, leading to continued... Read more

Industry

view channel
Image: The acquisition significantly expands Medix Biochemica’s portfolio of IVD raw materials (Photo courtesy of ViroStat)

Medix Biochemica Acquires US-Based ViroStat to Expand Infectious Diseases Antibody Offering

Medix Biochemica (Espoo, Finland), a supplier of critical raw materials to the in vitro diagnostics (IVD) industry, has acquired ViroStat LLC (Portland, ME, USA), a provider of infectious disease antibodies... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.